As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...

If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...

GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...

A discovery reveals that weight loss drugs like Ozempic and Mounjaro can positively impact 175 diseases and conditions beyond ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...

A new study reveals that popular diabetes and weight loss medications like Ozempic and Wegovy may offer unexpected health ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.

GLP-1 weight loss drugs - such as Wegovy and Mounjaro - may reduce risk of conditions including Alzheimer’s disease and ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...